Pravachol Faces Erosion, But Favorable Rebates Yield Q2 Sales Gain
This article was originally published in The Pink Sheet Daily
Executive Summary
Bristol-Myers Squibb’s cholesterol-lowering agent benefits from lower Medicaid and managed care rebate rates, helping drive 8% sales gain in U.S.